The striking loss of RGS6 in human UBC, together with our finding that an activating SNP in RGS6 is associated with a reduced risk of bladder cancer [20], strongly support the tumor suppressor role of RGS6 described here. This evidence concerns the gene RGS6 and urinary bladder cancer.